Indications & Dose:
Diabetes insipidus,
Adult and Child: initially 300 micrograms daily (in 3 divided doses); maintenance, 300-600 micrograms daily in 3 divided doses; range 0.21.2mg daily.
Primary nocturnal enuresis (with normal urine concentrating ability),
Adult: (under 65 years) and
Child: over 5 years (preferably over 7 years) 200 micrograms at bedtime, only increased to 400 micrograms if lower doses not effective (important: see also Cautions); withdraw for at least 1 week for reassessment after 3 months.
Postoperative polyuria/polydipsia,
adjust dose according to urine osmolality Intranasally
Diabetes insipidus, diagnosis,
Adult and child: 20mcg. Diabetes insipidus treatment – Adult 10-40mcg daily (in 1 or 2 divided doses)
Child : 5-20mcg. Infants may require lower doses.
Primary nocturnal enuresis (with normal urine concentrating ability),
Adult: (under 65 years) and \ Child over 5 years (preferably over 7 years) initially 20 micrograms at bedtime, only increased to 40 micrograms if lower dose not effective (important: see also Cautions); withdraw for at least 1 week for reassessment after 3 months
Nocturia associated with multiple sclerosis (when other treatments have failed),
Adult: (under 65 years) 10-20 micrograms at bedtime dose not to be repeated within 24 hours
Renal function testing (empty bladder at time of administration and limit fluid intake to 500mL from 1 hour before until 8 hours after administration),
Adult
40 micrograms;
Child: 1-15 years 20 micrograms, under 1 year 10 micrograms (restrict fluid intake to 50% at next 2 feeds to avoid fluid overload)
l BY INJECTIONS
Diabetes insipidus, diagnosis (subcutaneous or intramuscular).
Adult and Child: 2 micrograms (limit fluid intake to 500 mL from 1 hour before to 8 hours after administration)
Diabetes insipidus, treatment (subcutaneous, intramuscular or intravenous),
Adult: 1-4 micrograms daily;
Child: 400 micrograms
Renal function testing (empty bladder at time of administration and limit fluid intake to 500mL from 1 hour before until 8 hours after administration) (subcutaneous or intramuscular),
Adult and Child: 2 micrograms
Contraindications:
Type II B von Willebrand’s disease.
PREGNANCY, BREAST-FEEDING & OLD AGE:
Contraindicated.
Side Effects:
CNS: Drowsiness, flushing, headache, lethargy, seizures
CV: Increased blood pressure
EENT: Congestion, nasal irritation rhinitis
GI: Cramps, heartburn, nausea
GU: Vulvar pain
Cautions:
Precautions:
Coronary artery disease, hypertensive cardiovascular disease, elderly, children: for bleeding disorders, proven safe and effective for age >3 months (parenteral) or >11 months (Stimate intranasal).
Interaction:
Drugs
Analgesics: Effect of desmopressin potentiated by indomethacin
Warnings:
Adverse Effects:
Lactations:
Special Precautions:
Counselling:
Side Effects Or Adverse Reactions:
Patient And Carer Advice:
© Pakistan Drug Directory. All Rights Reserved.
Designed By: Pakistan Drug Directory Team